After booze, Marijuana has been credited with the second most drug related DUI in California which causes "impairment," California DUI attorneys learned today from the Clinical Chemistry journal and the 3/1/13 Science Daily report.
The study claims Marijuana is 2nd to alcohol for accidents and "impaired" driving, California DUI lawyers relate.
Release of this "study" comes at an expedient time when one California legislator is trying to pass per se DUI - drug laws. (See San Diego County DUI Law Center's article "Crazy California DUI 'drugged driving' bill tries to make it ZERO TOLERANCE for 'ANY' detectable drugs in one's system while driving.")
Marijuana, coincidentally, is purportedly now said to cause "detrimental effects" on the performance and maybe also on the "driving" of human being, claims the National Institute of Health (another government-related agency).
Questionable research suggests the so-called "desire" or "necessity" for doing something to decrease DUI - Marijuana. One conclusion is correct - "further studies" need to be done to try to truly determine - or at least have realistically investigated - safe driving and marijuana relationship based on dose-response.
Marijuana is detectable in daily tokers' blood for about thirty days after the last toke, according to the AACC's Clinical Chemistry journal. Three years ago, almost 13% of surveyed younger adults indicated they drove while DUI (drugs). A 5 year old National Roadside Survey indicates more drivers tested positive for drugs (including marijuana) than liquor. This inconclusive information claims to make a finding that marijuana tokers experience a tenfold increase in vehicle accident injury compared with not-so-frequent or non-marijuana users upon adjustment for BAC, whatever that means.
Of course the study conveniently overlooks the fact that the National Highway and Traffic Safety Administration long ago dismissed the idea that pscyhomotor impairment may be presumed from the detection of marijuana's active THC ingredient or is metabolite.
The publication goes on to suggest that now marijuana "cannabinoids" are detectable in chronic daily marijuana tokers for thirty days of sustained abstinence. The report suggests this is consistent with the "time course of persisting neurocognitive impairment." The National Institutes of Health's Dr. Huestis points out the data adds "critical information to the debate about the toxicity of chronic daily (marijuana) smoking" previously unavailable because of how hard and costly it was to study chronic daily smokers.